Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.00
-0.75 (-1.64%)
Nov 17, 2026, 1:30 PM CST

Medigen Vaccine Biologics Market Cap

Medigen Vaccine Biologics has a market cap or net worth of 14.79 billion as of November 17, 2026. It is the 14,806th most valuable company in the world and the 478th biggest in Taiwan. Its market cap has increased by 20.32% in one year.

Market Cap
14.79B
Enterprise Value
13.26B
Revenue
858.93M
Global Rank
Country Rank
#478 Taiwan
PE Ratio
n/a

Chart

Chart

Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 14.79B, an increase of 421.82%. That is a compound annual growth rate of 15.76%.

History

DateMarket Cap% Change
Nov 17, 202614.79B19.21%
Dec 31, 202512.41B4.72%
Dec 31, 202411.85B-48.55%
Dec 29, 202323.04B1.10%
Dec 30, 202222.78B-64.20%
Dec 30, 202163.65B192.75%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding